These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

159 related articles for article (PubMed ID: 10837716)

  • 1. The blood-brain barrier efflux transporters as a detoxifying system for the brain.
    Terasaki T; Hosoya K
    Adv Drug Deliv Rev; 1999 Apr; 36(2-3):195-209. PubMed ID: 10837716
    [TBL] [Abstract][Full Text] [Related]  

  • 2. In vivo evidence for carrier-mediated efflux transport of 3'-azido-3'-deoxythymidine and 2',3'-dideoxyinosine across the blood-brain barrier via a probenecid-sensitive transport system.
    Takasawa K; Terasaki T; Suzuki H; Sugiyama Y
    J Pharmacol Exp Ther; 1997 Apr; 281(1):369-75. PubMed ID: 9103519
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Physiological function of blood-brain barrier transporters as the CNS supporting and protecting system].
    Ohtsuki S
    Yakugaku Zasshi; 2004 Nov; 124(11):791-802. PubMed ID: 15516806
    [TBL] [Abstract][Full Text] [Related]  

  • 4. New aspects of the blood-brain barrier transporters; its physiological roles in the central nervous system.
    Ohtsuki S
    Biol Pharm Bull; 2004 Oct; 27(10):1489-96. PubMed ID: 15467183
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Role of drug efflux transporters in the brain for drug disposition and treatment of brain diseases.
    Löscher W; Potschka H
    Prog Neurobiol; 2005 May; 76(1):22-76. PubMed ID: 16011870
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Brain-to-blood transporters for endogenous substrates and xenobiotics at the blood-brain barrier: an overview of biology and methodology.
    Terasaki T; Ohtsuki S
    NeuroRx; 2005 Jan; 2(1):63-72. PubMed ID: 15717058
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Blood-brain barrier is involved in the efflux transport of a neuroactive steroid, dehydroepiandrosterone sulfate, via organic anion transporting polypeptide 2.
    Asaba H; Hosoya K; Takanaga H; Ohtsuki S; Tamura E; Takizawa T; Terasaki T
    J Neurochem; 2000 Nov; 75(5):1907-16. PubMed ID: 11032880
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Recent advances in the brain-to-blood efflux transport across the blood-brain barrier.
    Hosoya K; Ohtsuki S; Terasaki T
    Int J Pharm; 2002 Nov; 248(1-2):15-29. PubMed ID: 12429456
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Organic anion transporter 3 mediates the efflux transport of an amphipathic organic anion, dehydroepiandrosterone sulfate, across the blood-brain barrier in mice.
    Miyajima M; Kusuhara H; Fujishima M; Adachi Y; Sugiyama Y
    Drug Metab Dispos; 2011 May; 39(5):814-9. PubMed ID: 21325432
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Molecular mechanisms of drug influx and efflux transport at the blood-brain barrier].
    Ohtsuki S; Hori S; Terasaki T
    Nihon Yakurigaku Zasshi; 2003 Jul; 122(1):55-64. PubMed ID: 12843573
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Kinetic and biochemical analysis of carrier-mediated efflux of drugs through the blood-brain and blood-cerebrospinal fluid barriers: importance in the drug delivery to the brain.
    Sugiyama Y; Kusuhara H; Suzuki H
    J Control Release; 1999 Nov; 62(1-2):179-86. PubMed ID: 10518649
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Brain distribution of 6-mercaptopurine is regulated by the efflux transport system in the blood-brain barrier.
    Deguchi Y; Yokoyama Y; Sakamoto T; Hayashi H; Naito T; Yamada S; Kimura R
    Life Sci; 2000; 66(7):649-62. PubMed ID: 10794520
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Distributed model analysis of 3'-azido-3'-deoxythymidine and 2',3'-dideoxyinosine distribution in brain tissue and cerebrospinal fluid.
    Takasawa K; Terasaki T; Suzuki H; Ooie T; Sugiyama Y
    J Pharmacol Exp Ther; 1997 Sep; 282(3):1509-17. PubMed ID: 9316866
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Kinetic evidence for active efflux transport across the blood-brain barrier of quinolone antibiotics.
    Ooie T; Terasaki T; Suzuki H; Sugiyama Y
    J Pharmacol Exp Ther; 1997 Oct; 283(1):293-304. PubMed ID: 9336336
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Brain-to-blood efflux transport of estrone-3-sulfate at the blood-brain barrier in rats.
    Hosoya K; Asaba H; Terasaki T
    Life Sci; 2000 Oct; 67(22):2699-711. PubMed ID: 11105986
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Selective brain to blood efflux transport of para-aminohippuric acid across the blood-brain barrier: in vivo evidence by use of the brain efflux index method.
    Kakee A; Terasaki T; Sugiyama Y
    J Pharmacol Exp Ther; 1997 Dec; 283(3):1018-25. PubMed ID: 9399971
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Kinetic analysis of the disposition of hydrophilic drugs in the central nervous system (CNS): prediction of the CNS disposition from the transport properties in the blood-brain and blood-cerebrospinal fluid barriers].
    Suzuki H; Sugiyama Y
    Yakugaku Zasshi; 1994 Dec; 114(12):950-71. PubMed ID: 7869236
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Transporter-mediated permeation of drugs across the blood-brain barrier.
    Tamai I; Tsuji A
    J Pharm Sci; 2000 Nov; 89(11):1371-88. PubMed ID: 11015683
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Application of in vivo brain microdialysis to the study of blood-brain barrier transport of drugs.
    Deguchi Y
    Drug Metab Pharmacokinet; 2002; 17(5):395-407. PubMed ID: 15618691
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Involvement of multiple transporters in the efflux of 3-hydroxy-3-methylglutaryl-CoA reductase inhibitors across the blood-brain barrier.
    Kikuchi R; Kusuhara H; Abe T; Endou H; Sugiyama Y
    J Pharmacol Exp Ther; 2004 Dec; 311(3):1147-53. PubMed ID: 15292460
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.